MedPath

EndoStim Patient Registry

Terminated
Conditions
GERD
Registration Number
NCT02441400
Lead Sponsor
EndoStim Inc.
Brief Summary

To provide a research tool enabling physicians to monitor long term clinical outcomes for patients undergoing gastroesophageal reflux disease (GERD) treatment with EndoStim LES Stimulation System.

Detailed Description

The EndoStim Patient Registry provides a framework for data collection on patients with GERD treated with the EndoStim LES Stimulation System. The primary objective is to provide a tool for participating physician investigators to collect and analyze outcomes data related to the use of the EndoStim LES Stimulation System.

This is a prospective, multi-center patient Registry. Sites may choose to also retrospectively enroll previously treated patients (after obtaining informed consent) and enter retrospective data into case report forms paper or on-line.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
350
Inclusion Criteria
  1. Subject meets therapy indications
  2. Subject signs informed consent
  3. Subject has a planned EndoStim LES Stimulation System implant (prospective) OR subject has already had EndoStim LES Stimulation System implant (retrospective)
Exclusion Criteria
  1. Subject meets therapy contraindications

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence and severity of adverse events5 years post-implant

Safety will be assessed by incidence and severity of adverse events through 5 years of follow-up

Secondary Outcome Measures
NameTimeMethod
Change in GERD-HRQLChange in GERD-HRQL questionnaire score will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline GERD-HRQL

Comparison of pH valuesThe pH values of % 24-hour esophageal pH < 4.0, and the number of reflux events > 1 minute and > 5 minutes will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in the following (while off PPI): % 24-hour esophageal pH\<4.0, and number of reflux events \>1 minute and \> 5 minutes

Comparison of symptoms and quality of lifeSymptoms will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in symptoms (measured by patient diary) and in quality of life (measured by SF-12)

Change in antisecretory medication useThe use of antisecretory medication will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in antisecretory medication use

Change in Structured GI Questionnaire responses (vs. baseline)Symptoms will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline on Structured GI Questionnaire responses

Change in sleep related quality of lifeSleep related quality of life will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in sleep related quality of life (measured by Pittsburgh Sleep Quality Index)

Change in work productivity impairmentWork productivity will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in work productivity impairment (measured by Work Productivity and Activity Impairment Questionnaire)

Change in Reflux Disease Questionnaire (RDQ) scoresRDQ questionnaire score will be assessed at baseline, 3-6 months post implant, and then annually until 5 years

Change from baseline in RDQ scores

Trial Locations

Locations (30)

Fundacion Favaloro

🇦🇷

Buenos Aires, Argentina

University Hospital Vienna

🇦🇹

Vienna, Austria

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

SANA Klinikum Lichtenberg

🇩🇪

Berlin, Germany

Evangelisches Krankenhaus Castrop-Rauxel

🇩🇪

Castrop Rauxel, Germany

St. Marienstift Krankenhaus Friesoythe

🇩🇪

Friesoythe, Germany

Hospital zum Heiligen Geist Fritzlar

🇩🇪

Fritzlar, Germany

Klinikum Garmisch-Partenkirchen

🇩🇪

Garmisch-Partenkirchen, Germany

Wolfartklinik Graefelfing

🇩🇪

Gräfelfing, Germany

Martha Maria Krankenhaus Halle-Dölau

🇩🇪

Halle, Germany

Scroll for more (20 remaining)
Fundacion Favaloro
🇦🇷Buenos Aires, Argentina

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.